Delivery Order SPE2DB24D1007-SPE2DB25FCCTV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,490.76 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,117.71 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed price delivery order with no set-aside provision, carries an ultimate completion date of August 26, 2025, and represents a competitively awarded procurement. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,336.48 on July 31, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 1, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,220.35 on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with a completion date of July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,910.72 delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $69,181.35 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $72,974.58 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCTVDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, for the supply of Sunosi 75 mg tablets (30-count) with a ceiling value of $1,042.97. This firm fixed-price contract was funded by the Defense Logistics Agency (DLA) under its defense medical supply operations. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. Performance is scheduled for completion by August 8, 2025, with the work to be performed at the company's Conshohocken, Pennsylvania facility. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to the federal government, particularly supporting military and veteran healthcare systems. The Pharmaceutical Prime Vendor Global Program contract vehicle through which this order was issued enables DLA to efficiently procure a broad range of medications and medical supplies to support Defense Health Agency operations and other government healthcare beneficiaries. AmerisourceBergen's comprehensive portfolio of federal contracts demonstrates its versatility in fulfilling diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to generic drugs and vaccines, positioning the company as a strategic partner in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/7/25 |